Gland Pharma Shares Jump 5% After US FDA Approval for Vitamin K Deficiency Injectable – What’s Next?
In early Thursday morning trading, Gland Pharma’s shares jumped to 4.76 percent at Rs 1860 on the BSE following the company’s medication approval from the US Food and medication Administration (USFDA). Phytonadione Injectable Emulsion was approved by the USFDA for the generic medication manufacturer. The vitamin K1 injectable emulsion from Hospira, Inc. is the reference … Read more
